Aoxing Biotechnology
Aoxing Biotechnology, also known as Aoxing International, is a prominent player in the biotechnology sector, headquartered in China (CN). Founded in 2001, the company has established itself as a leader in the development and manufacturing of innovative pharmaceutical products, particularly in the fields of pain management and addiction treatment. With a strong operational presence across Asia and expanding into global markets, Aoxing Biotechnology focuses on producing unique formulations that address critical healthcare needs. Their core offerings include a range of controlled substances and advanced drug delivery systems, distinguished by their commitment to quality and regulatory compliance. Recognised for its significant contributions to the industry, Aoxing Biotechnology continues to enhance its market position through strategic partnerships and research initiatives, solidifying its reputation as a trusted name in biotechnology.
DitchCarbon Score
How does Aoxing Biotechnology's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aoxing Biotechnology's score of 0 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Aoxing Biotechnology's reported carbon emissions
Aoxing Biotechnology, headquartered in CN, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the absence of reported emissions may indicate a need for enhanced transparency in their environmental strategies. As the biotechnology industry increasingly prioritises sustainability, Aoxing Biotechnology's future climate commitments will be crucial in aligning with global efforts to reduce greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aoxing Biotechnology is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
